This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 May 30;351(9116):1660-1.

doi: 10.1016/S0140-6736(05)77719-9.

Ribavirin and immune thrombocytopenic purpura

A Jaccard, V Loustaud, P Turlure, S Rogez, D Bordessoule

PMID: 9620744
DOI: 10.1016/S0140-6736(05)77719-9

Case Reports

Ribavirin and immune thrombocytopenic purpura

A Jaccard et al. Lancet. 1998.

. 1998 May 30;351(9116):1660-1.

doi: 10.1016/S0140-6736(05)77719-9.

Authors

A Jaccard, V Loustaud, P Turlure, S Rogez, D Bordessoule

PMID: 9620744
DOI: 10.1016/S0140-6736(05)77719-9

No abstract available

PubMed Disclaimer

Comment on

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.
Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O. Reichard O, et al. Lancet. 1998 Jan 10;351(9096):83-7. doi: 10.1016/s0140-6736(97)06088-1. Lancet. 1998. PMID: 9439491 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.